XML 69 R56.htm IDEA: XBRL DOCUMENT v3.22.0.1
Commitments and Contingencies (Tables)
12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Operating Lease, Lease Income
For the year ended December 31, 2021, 2020 and 2019, quantitative information regarding the Company's operating lease obligations reflected in the accompanying consolidated statements of operations were as follows:
Year Ended December 31,
202120202019
(dollars in thousands)
Lease cost
Operating lease cost$25,268 $22,759 $23,540 
Short-term lease cost150 207 253 
Variable lease cost 3,526 3,550 3,580 
Sublease income(583)(781)(953)
Total lease costs$28,361 $25,735 $26,420 
The following table summarizes the supplemental cash flow information and certain other information related to operating leases for the years ended December 31, 2021 and 2020:
Year Ended December 31,
20212020
(dollars in thousands)
Other information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$27,429 $25,012 
Weighted average remaining lease term - operating leases (in years)5.274.58
Weighted average discount rate - operating leases4.06 %3.66 %
Future Minimum Annual Lease and Service Payments
As of December 31, 2021, maturities of the outstanding operating lease liabilities for the Company were as follows:
Equipment Leases (operating) (d)Real Estate and Other Facility Rental (a) (b) (c)
 (dollars in thousands)
2022$520 $24,697 
2023381 24,687 
2024370 21,852 
2025370 11,137 
2026278 7,593 
Thereafter— 19,463 
Total operating leases1,919 109,429 
Less discount124 12,232 
Less short-term leases— 109 
Total lease liability$1,795 $97,088 
(a)The Company has entered into various agreements to sublease certain of its premises.
(b)During the year ended December 31, 2021, the Company recognized an increase of $37.7 million of operating right-of-use assets and leases liabilities related to facility leases.
(c)During the fourth quarter of 2021, the Company completely vacated leased office space in New York and New Jersey which resulted in an acceleration of expense of approximately $0.9 million within occupancy and equipment expense in the accompanying consolidated statements of operations during the year ended December 31, 2021.
(d)During the year ended December 31, 2021, the Company recognized an increase of $1.7 million of operating right-of-use assets and leases liabilities related to equipment leases.
As of December 31, 2021, future minimum annual service payments for the Company were as follows:
Service Payments
 (dollars in thousands)
2022$25,085 
202312,511 
20245,254 
20253,366 
20263,237 
Thereafter7,357 
Total service payment commitments$56,810 
Other Commitments The following table summarizes unfunded commitments as of December 31, 2021:
EntityUnfunded CommitmentsCommitment Term
(dollars in thousands)
HealthCare Royalty Partners funds (a)$3,886 3 years
Eclipse Ventures Fund I, L.P.$28 3 years
Eclipse Fund II, L.P.$23 4 years
Eclipse Continuity Fund I, L.P.$20 5 years
Cowen Healthcare Investments III LP$2,632 5 years
Cowen Healthcare Investments IV LP$6,399 6 years
Cowen Sustainable Investments I LP$14,643 8 years
(a) The Company is a limited partner of the HealthCare Royalty Partners funds (which are managed by Healthcare Royalty Management) and is a member of HealthCare Royalty Partners General Partners. The Company will make its pro-rata investment in the HealthCare Royalty Partners funds along with the other limited partners.